DPP4 and polycystic ovary syndrome: Different diabetic medicines like the insulin-sensitizing treatment in PCOS-glucagon-like peptide-1 receptor agonists (GLP-1RAs), dipeptidyl peptidase 4 (DPP-4) inhibitors, and sodium-glucose cotransporter (SGLT2) inhibitors could also be considered as a part of the treatment of PCOS [29,30].